Lewis Sanders
Sanders Capital
Sanders Capital Portfolio 13F
Lewis Sanders Holdings Activity
- Portfolio value:
- $37.90B≈ (+$9B≈)
- Previous value:
- $29.15B≈
- # of changes:
- 40
- New positions:
- 1
- Reported for:
- 31 Dec 2020 (Q4)
- Latest filing date:
- 07 Sep 2022
Sanders Capital has disclosed a total of 40 changes to the portfolio in the (2020 Q4) SEC report(s): increased the number of shares of 28, bought 1 totally new, decreased the number of shares of 9 and completely sold out 2 position(s).
What stocks did Lewis Sanders buy in 2020 Q4?
During 2020 Q4 Lewis Sanders has bought 29 securities out of which top 5 purchases (by % change to portfolio) were (TSM) Taiwan Semiconductor Manufacturing (added shares +6.42%), (GOOG) Alphabet Inc, CL-C (added shares +11.58%), (MU) Micron Technology Inc (added shares +13.87%), (AAPL) Apple Inc (added shares +9.05%) and (UNH) UnitedHealth Group Incorporated (added shares +9.51%).
What did Lewis Sanders invest in during 2020 Q4?
In the 2020 Q4 report(s) the following changes have been made to the top investments: (TSM) Taiwan Semiconductor Manufacturing (added shares +6.42%), (GOOG) Alphabet Inc, CL-C (added shares +11.58%), (MU) Micron Technology Inc (added shares +13.87%), (AAPL) Apple Inc (added shares +9.05%) and (UNH) UnitedHealth Group Incorporated (added shares +9.51%).
40 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Johnson & Johnson
|
new
|
$157.38
|
+63.85%($257.86)
|
2.74%
|
2020 Q4
|
≈ 0.25 years
|
||||
|
|
JPMorgan Chase & Co
|
+364.43%
|
$127.07
|
+178.32%($353.66)
|
4.09%
|
2013 Q2 or earlier
|
≈ 7.75+ years
|
||||
|
|
Tyson Foods Inc
|
+359.91%
|
$64.44
|
-7.22%($59.79)
|
0.40%
|
2020 Q2
|
≈ 0.75 years
|
||||
|
|
Wells Fargo & Company
|
+352.27%
|
$30.18
|
+186.05%($86.33)
|
3.74%
|
2018 Q2
|
≈ 2.75 years
|
||||
|
|
ING Group NV ADR
|
+127.42%
|
$9.44
|
+271.05%($35.03)
|
0.00%
|
2020 Q3
|
≈ 0.50 years
|
||||
|
|
Vanguard FTSE All-World ex-US Index Fund ETF Shares
|
+66.81%
|
$58.36
|
+42.31%($83.05)
|
2.84%
|
2013 Q2 or earlier
|
≈ 7.75+ years
|
||||
|
|
Citigroup Inc
|
+27.19%
|
$61.66
|
+115.93%($133.14)
|
4.20%
|
2013 Q2 or earlier
|
≈ 7.75+ years
|
||||
|
|
Synchrony Financial
|
+20.26%
|
$34.71
|
+119.27%($76.11)
|
0.50%
|
2015 Q4
|
≈ 5.25 years
|
||||
|
|
Merck & Company Inc
|
+16.23%
|
$81.80
|
+59.74%($130.66)
|
0.16%
|
2015 Q2
|
≈ 5.75 years
|
||||
|
|
Meta Platforms Inc
|
+15.35%
|
$273.16
|
+101.05%($549.19)
|
4.92%
|
2018 Q3
|
≈ 2.50 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.